Peptide Therapeutics Market Will Reach USD 43.26 Billion By 2024, Globally: Zion Market Research

According to the report, global peptide therapeutics market was valued at approximately USD 23.05 billion in 2017 and is expected to generate revenue of around USD 43.26 billion by the end of 2024, growing at a CAGR of around 9.41% between 2018 and 2024.

New York, NY, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Peptide Therapeutics Market by Route of Administration (Parenteral, Oral, and Others), by Type (Innovative and Generic), by Type of Manufacturers (In-house and Outsourced), by Type of Molecule (Vasopressin, Somatostatin, Calcitonin, Immunopeptide, Natriuretic, and Others), by Technology (Liquid Phase, Solid Phase, and Hybrid Phase), and by Application (Cancer, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Infectious Disease, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024”. According to the report, global peptide therapeutics market was valued at approximately USD 23.05 billion in 2017 and is expected to generate revenue of around USD 43.26 billion by the end of 2024, growing at a CAGR of around 9.41% between 2018 and 2024.

The peptide is a type of selective signaling molecule which binds to the cell-specific surface receptors or ion channels which helps to trigger the response for different functions of the cell for specific diseases. Due to the rapid increase in research for peptide therapeutics and an increase in the awareness levels about them is mainly fueling the growth of the peptide therapeutics market.

Browse through 105 Tables & 44 Figures spread over 110 Pages and in-depth TOC on “Global Peptide Therapeutics Market Size 2017: By Type, Industry Share, Trends, Growth Analysis and Forecast to 2024”.

Request Free Sample Report of Global Peptide Therapeutics Market Report @ https://www.zionmarketresearch.com/sample/peptide-therapeutics-market

Peptide therapeutics market is segmented on the route of administration, type, type of manufacturers, type of molecule, technology, and application. Based on the route of administration, the market is divided into parenteral, oral, and others. The oral segment is anticipated to show the fastest growth rate, but parenteral segment dominates the route of administration segment. The easy availability of peptide drugs in the form which can be administered through parenteral route is fueling the demand for the parenteral segment.

On the basis of type, the peptide therapeutics market is further segmented into generic and innovative. The increase in investment by many pharmaceutical companies for the development of new drugs is fueling the demand for the innovative type of peptide therapeutics.

Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/peptide-therapeutics-market

Type of manufacturers includes in-house and outsourced segment. The in-house manufacturing segment held the largest share of the manufacturer type segment. Stringent regulations in different regions are anticipated to impact the growth of the outsourced manufacturing segment.

Based on the type of molecule, the market for peptide therapeutics is segmented into natriuretic, somatostatin, vasopressin, immunopeptide, calcitonin, and others.

On the basis of technology, the market for peptide therapeutics is further segmented into the liquid phase, solid phase, and hybrid phase. The liquid phase is anticipated to dominate the peptide therapeutics market due to the increase in the demand for the pure peptides which can easily be obtained through the use of liquid phase technology.

Request for The Discount on This Report: https://www.zionmarketresearch.com/requestdiscount/peptide-therapeutics-market

The application segment includes cancer, metabolic disease, cardiovascular disease, infectious disease, respiratory disease, and others. The cancer segment is anticipated to dominate the application segment of the market for peptide therapeutics. The rise in death rate due to cancer and the increase in research activities for treating cancer patients are some of the major factors fueling the use of peptide therapeutics for cancer treatment.

North America is anticipated to govern the global peptide therapeutics market during the forecast period. In 2015, North America approximately held 38% of the overall global peptide therapeutics market share. According to the National Cancer Institute, in 2018, approximately 1.7 million new cases of cancer will be diagnosed in the U.S. The use of peptide therapeutics as a drug to treat cancer and various diseases and rising use of these drugs are mainly fueling the growth of the market for peptide therapeutics in North America. The rising incidences of chronic diseases such as cancer and the presence of advanced healthcare infrastructure are some of the key factors fueling the growth of the peptide therapeutics market in the region. Also, the rapidly growing biotechnology and biopharmaceutical industries and an increase in the investments in the research activities by the government are also driving the growth of the North American peptide therapeutics market.

Browse the full "Peptide Therapeutics Market by Route of Administration (Parenteral, Oral, and Others), by Type (Innovative and Generic), by Type of Manufacturers (In-house and Outsourced), by Type of Molecule (Vasopressin, Somatostatin, Calcitonin, Immunopeptide, Natriuretic, and Others), by Technology (Liquid Phase, Solid Phase, and Hybrid Phase), and by Application (Cancer, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Infectious Disease, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024" report at https://www.zionmarketresearch.com/report/peptide-therapeutics-market

In the upcoming years, Europe is anticipated to be the second most lucrative market for peptide therapeutics. The increase in prevalence of metabolic disorders, inflammatory diseases, and cardiovascular diseases due to rapid rise in the aging population will fuel the demand for peptide therapeutics market in European region. Also, increase in the pharmaceutical research activities and rise in investments in this industry along with rising awareness about the peptide therapy anticipate propelling the growth of the peptide therapeutics market in Europe.

In the forecast period, Asia Pacific is expected to show the fastest growth among all the regions. According to the WHO (World Health Organization), around 1 million people in the Western Pacific die from cardiovascular disorders (CVD)every year. This increase in the occurrence of CVD and cancer among the patient population is anticipated to drive the growth of the peptide therapeutics market in the Asia Pacific region. Also, the increased investment in biotechnology & pharmaceutical industry by government and companies are projected to spur the growth of the peptide therapeutics market. The rise in awareness about the peptide therapeutics and drug innovations is some of the growth drivers of the peptide therapeutics market. Also, the presence of established API providers and generic drug firms with the stable economy rate in some countries of Asia Pacific are also contributing to the growth of the peptide therapeutics market in this region.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/peptide-therapeutics-market

Latin America is expected to show a comparatively high growth rate in the forecast period as compared to the Middle East & Africa. The rapid adoption of the western lifestyle has increased the incidences of heart-related diseases and increase in investments by various companies is some of the key factors projected to fuel the growth of the peptide therapeutics market in this region.

The main players in the global peptide therapeutics market are Amgen Inc., Pfizer Inc., Eli Lilly and Company, Teva Pharmaceuticals Industries Ltd., Lonza Inc., Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb, Sanofi, AstraZeneca PLC, and Novartis AG. The key companies focus on the development of new peptide drugs for treatment for various diseases.

Request customized copy of report @ https://www.zionmarketresearch.com/custom/3439

This report segments the global peptide therapeutics market as follows:

Global Peptide Therapeutics Market: Route of Administration Segment Analysis

  • Parenteral
  • Oral
  • Others

Global Peptide Therapeutics Market: Type Segment Analysis

  • Innovative
  • Generic

Global Peptide Therapeutics Market: Type of Manufacturers Segment Analysis

  • In-house
  • Outsourced

Global Peptide Therapeutics Market: Type of Molecule Segment Analysis

  • Vasopressin
  • Somatostatin
  • Calcitonin
  • Immunopeptide
  • Natriuretic
  • Others

Global Peptide Therapeutics Market: Technology Segment Analysis

  • Solid Phase
  • Liquid Phase
  • Hybrid Phase

Global Peptide Therapeutics Market: Application Segment Analysis

  • Cancer
  • Cardiovascular Disease
  • Metabolic Disease
  • Respiratory Disease
  • Infectious Disease
  • Others

Global Peptide Therapeutics Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research

Blog: http://www.intenseresearch.com | http://www.mrsresearchgroup.com | http://www.marketresearchtrade.com | https://qyresearchgroup.com | http://marketnreports.com | https://zmrnewsjournal.us | http://www.e-marketresearch.com

Contact Us:

Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com

Website: https://www.zionmarketresearch.com

Blog: http://zmrblog.com

Ads